| Autor: |
Pasricha SR; Population Health and Immunity Division and World Health Organization Collaborating Centre for Anaemia Detection and Control, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia; Clinical Haematology, The Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Rogers L; Department of Nutrition and Food Safety, World Health Organization, Geneva 1202, Switzerland., Branca F; Department of Nutrition and Food Safety, World Health Organization, Geneva 1202, Switzerland., Garcia-Casal MN; Department of Nutrition and Food Safety, World Health Organization, Geneva 1202, Switzerland. Electronic address: garciacasalm@who.int. |
| Abstrakt: |
Competing Interests: S-RP reports grants to his institution from the Australian National Health and Medical Research Council (NHMRC) and the Bill & Melinda Gates Foundation, providing salary and research support; funding by NHMRC Fellowships GNT1158696 and GNT2009047; paid advisory board roles for CSL-Vifor for iron and immunity and for vamifeport in sickle cell disease; consultancy work for ITL Biomedical on point-of-care devices in iron; research support from WHO; unpaid roles at WHO as Director (WHO Collaborating Centre for Anaemia Detection and Control) and co-Chair (Guideline Development Group Meetings); and is co-inventor of a patent (WO/2022/229150) for use of SLN124 for polcythaemia vera. LR, FB, and M-NG-C are staff members of WHO and report financial support to the work of the WHO Department of Nutrition and Food Safety from USAID, US Centers for Disease Control and Prevention, and the Bill & Melinda Gates Foundation. LR is a member of the Technical Advisory Group for the study on Redefining Maternal Anemia in Pregnancy and Postpartum (ReMAPP): a multicenter, international, population-based study to establish global hemoglobin thresholds for maternal anemia; and is a member of the Technical Advisory Group for a study assessing the role of micronutrients through child health and mortality prevention surveillance. We all contributed to the development of the WHO guideline(15) discussed here. The conclusions in this Comment are those of the authors and do not necessarily represent the official position of WHO. |
